Feb 2025 Novel Psychoactive Substances 2024: A Year in Review
New or Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of prescription...
Clinical Update
10 Dec Aegis Sciences Corporation Announces Updates for NPS Testing
in
News
NASHVILLE, TN. (December 10, 2024) – Aegis Sciences Corporation, a health care testing lab based in Nashville, TN, is pleased...
Nov 2024 Ketamine: Considerations in Clinical Practice
Ketamine is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. It is FDA approved for the induction and maintenance of anesthesia.1 When used...
Jun 2024 New Nitazene Data – Ongoing Evaluation of an Emerging Threat
Gabapentin (Neurontin, Gralise, Horizant) was first approved by the US Food and Drug Administration (FDA) in 1993 for the treatment...
30 May The Center for Forensic Science Research & Education (CFSRE) Publishes An Alert Regarding 2F-2oxo-PCE
in
News
On May 30, 2024, The Center for Forensic Science Research & Education (CFSRE) published an alert regarding 2F-2oxo-PCE...
22 May Aegis Clinical Team Members Discuss the Dangers of Tianeptine Misuse with Drug Topics Magazine
in
News
Aegis Sciences Corporation, a health care testing lab based in Nashville, TN, recently had two members of its Clinical Team...
